RIOK2 Contributes to Cell Growth and Protein Synthesis in Human Oral Squamous Cell Carcinoma

被引:2
|
作者
Matsuzaki, Yusuke [1 ,2 ]
Naito, Yutaka [1 ]
Miura, Nami [1 ]
Mori, Taisuke [3 ]
Watabe, Yukio [4 ]
Yoshimoto, Seiichi [5 ]
Shibahara, Takahiko [2 ]
Takano, Masayuki [2 ]
Honda, Kazufumi [1 ,6 ]
机构
[1] Nippon Med Sch, Inst Adv Med Sci, Dept Bioregulat, Tokyo 1138602, Japan
[2] Tokyo Dent Coll, Dept Oral & Maxillofacial Surg, Tokyo 1010061, Japan
[3] Natl Canc Ctr, Dept Diagnost Pathol, Tokyo 1040045, Japan
[4] Tokyo Metropolitan Tama Med Ctr, Dept Dent & Oral Surg, Tokyo 1838524, Japan
[5] Natl Canc Ctr, Dept Head & Neck Surg, Tokyo 1040045, Japan
[6] Nippon Med Sch, Grad Sch Med, Dept Bioregulat, Tokyo 1138602, Japan
关键词
RIOK2; biomarker; tongue squamous cell carcinoma; ribosome; protein synthesis; RIBOSOME BIOGENESIS; CANCER;
D O I
10.3390/curroncol30010031
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ribosomes are responsible for the protein synthesis that maintains cellular homeostasis and is required for the rapid cellular division of cancer cells. However, the role of ribosome biogenesis mediators in the malignant behavior of tongue squamous cell carcinoma (TSCC) is unknown. In this study, we found that the expression of RIOK2, a key enzyme involved in the maturation steps of the pre-40S ribosomal complex, was significantly associated with poorer overall survival in patients with TSCC. Further, multivariate analysis revealed that RIOK2 is an independent prognostic factor (hazard ratio, 3.53; 95% confidence interval, 1.19-10.91). Inhibition of RIOK2 expression by siRNA decreased cell growth and S6 ribosomal protein expression in oral squamous cell carcinoma cell lines. RIOK2 knockdown also led to a significant decrease in the protein synthesis in cancer cells. RIOK2 has potential application as a novel therapeutic target for TSCC treatment.
引用
收藏
页码:381 / 391
页数:11
相关论文
共 50 条
  • [1] Identification of RIOK2 as a master regulator of human blood cell development
    Shrestha Ghosh
    Mahesh Raundhal
    Samuel A. Myers
    Steven A. Carr
    Xi Chen
    Gregory A. Petsko
    Laurie H. Glimcher
    Nature Immunology, 2022, 23 : 109 - 121
  • [2] Identification of RIOK2 as a master regulator of human blood cell development
    Ghosh, Shrestha
    Raundhal, Mahesh
    Myers, Samuel A.
    Carr, Steven A.
    Chen, Xi
    Petsko, Gregory A.
    Glimcher, Laurie H.
    NATURE IMMUNOLOGY, 2022, 23 (01) : 109 - +
  • [3] Targeting RIOK2 ATPase activity leads to decreased protein synthesis and cell death in acute myeloid leukemia
    Messling, Jan-Erik
    Agger, Karl
    Andersen, Kasper L.
    Kromer, Kristina
    Kuepper, Hanna M.
    Lund, Anders H.
    Helin, Kristian
    BLOOD, 2022, 139 (02) : 245 - 255
  • [4] Atypical Kinase RIOK2 Is a Master Regulator of Hematopoietic Cell Fate
    Ghosh, Shrestha
    Raundhal, Mahesh
    Myers, Samuel A.
    Carr, Steven A.
    Chen, Xi
    Petsko, Gregory A.
    Glimcher, Laurie H.
    BLOOD, 2021, 138
  • [5] Protein phosphatase 1α regulates oral squamous cell carcinoma cell growth
    Hsu, Lih-Ching
    Barua, Suman
    Gollin, Susanne M.
    CANCER RESEARCH, 2006, 66 (08)
  • [6] RIOK2 phosphorylation by RSK promotes synthesis of the human small ribosomal subunit
    Cerezo, Emilie L.
    Houles, Thibault
    Lie, Oriane
    Sarthou, Marie-Kerguelen
    Audoynaud, Charlotte
    Lavoie, Genevieve
    Halladjian, Maral
    Cantaloube, Sylvain
    Froment, Carine
    Burlet-Schiltz, Odile
    Henry, Yves
    Roux, Philippe P.
    Henras, Anthony K.
    Romeo, Yves
    PLOS GENETICS, 2021, 17 (06):
  • [7] Stanniocalcin 2 contributes to aggressiveness and is a prognostic marker for oral squamous cell carcinoma
    do Carmo, Andreia Ferreira
    Dourado, Mauricio Rocha
    de Oliveira, Carine Ervolino
    Bastos, Debora Campanella
    Domingueti, Catherine Bueno
    Ribeiro Paranaiba, Livia Maris
    Sawazaki-Calone, Iris
    Borges, Gabriel Alvares
    Silva Guerra, Eliete Neves
    Casarin, Renato C.
    Graner, Edgard
    Salo, Tuula A.
    Freitas, Roseana de Almeida
    Galvao, Hebel Cavalcanti
    Coletta, Ricardo D.
    EXPERIMENTAL CELL RESEARCH, 2020, 393 (02)
  • [8] ASC contributes to metastasis of oral cavity squamous cell carcinoma
    Wu, Chi-Sheng
    Chang, Kai-Ping
    OuYang, Chun-Nan
    Kao, Huang-Kai
    Hsueh, Chuen
    Chen, Lih-Chyang
    Cheng, Hsiao-Yun
    Liang, Ying
    Liou, Willisa
    Liang, Chih-Lung
    Chang, Yu-Sun
    ONCOTARGET, 2016, 7 (31) : 50074 - 50085
  • [9] Overexpression of absent in melanoma 2 in oral squamous cell carcinoma contributes to tumor progression
    Nakamura, Yuri
    Nakahata, Shingo
    Kondo, Yuudai
    Izumi, Aya
    Yamamoto, Koji
    Ichikawa, Tomonaga
    Tamura, Tomohiro
    Noumi, Kenta
    Yamashita, Yoshihiro
    Morishita, Kazuhiro
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 509 (01) : 82 - 88
  • [10] Effects of TGF-β on Growth and Invasion of Human Oral Squamous Cell Carcinoma Cell Lines
    Ishiguro-katsuta, Hitoe
    Okada, Yasuo
    JOURNAL OF HARD TISSUE BIOLOGY, 2022, 31 (03) : 171 - 180